Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 36 | 2022 | 3612 | 2.530 |
Why?
|
| Artifacts | 6 | 2022 | 248 | 1.420 |
Why?
|
| Head | 6 | 2022 | 135 | 1.410 |
Why?
|
| Thermography | 3 | 2021 | 13 | 1.370 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 3 | 2025 | 54 | 0.910 |
Why?
|
| Surgery, Computer-Assisted | 4 | 2021 | 121 | 0.850 |
Why?
|
| Neck | 3 | 2022 | 103 | 0.850 |
Why?
|
| Contrast Media | 11 | 2018 | 1013 | 0.800 |
Why?
|
| Patient Safety | 2 | 2016 | 235 | 0.760 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2022 | 2678 | 0.760 |
Why?
|
| Image Interpretation, Computer-Assisted | 11 | 2015 | 643 | 0.720 |
Why?
|
| Protons | 4 | 2021 | 102 | 0.720 |
Why?
|
| Prostate | 5 | 2018 | 434 | 0.690 |
Why?
|
| Image Enhancement | 10 | 2016 | 503 | 0.650 |
Why?
|
| Brain | 8 | 2020 | 2439 | 0.650 |
Why?
|
| Dogs | 6 | 2018 | 642 | 0.630 |
Why?
|
| White Matter | 1 | 2020 | 100 | 0.580 |
Why?
|
| Stroke | 2 | 2020 | 1167 | 0.570 |
Why?
|
| Silicon Dioxide | 1 | 2018 | 40 | 0.560 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2021 | 271 | 0.550 |
Why?
|
| Algorithms | 10 | 2018 | 2003 | 0.520 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2017 | 15 | 0.510 |
Why?
|
| Pattern Recognition, Automated | 4 | 2011 | 218 | 0.510 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 1088 | 0.500 |
Why?
|
| Radiation Dosage | 3 | 2014 | 232 | 0.480 |
Why?
|
| Equipment Safety | 1 | 2016 | 29 | 0.470 |
Why?
|
| Intracranial Hemorrhages | 1 | 2017 | 138 | 0.470 |
Why?
|
| Occupational Diseases | 1 | 2016 | 58 | 0.450 |
Why?
|
| Thrombectomy | 1 | 2017 | 265 | 0.420 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2014 | 24 | 0.420 |
Why?
|
| Radiation Injuries | 1 | 2015 | 160 | 0.410 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2011 | 283 | 0.390 |
Why?
|
| Radiology | 1 | 2015 | 215 | 0.370 |
Why?
|
| Education, Medical | 1 | 2015 | 229 | 0.370 |
Why?
|
| Circle of Willis | 2 | 2011 | 5 | 0.350 |
Why?
|
| Axilla | 1 | 2011 | 109 | 0.340 |
Why?
|
| Ultrasonography | 3 | 2021 | 720 | 0.340 |
Why?
|
| Neuronavigation | 5 | 2012 | 26 | 0.330 |
Why?
|
| Phantoms, Imaging | 4 | 2019 | 493 | 0.330 |
Why?
|
| Neuroimaging | 1 | 2011 | 143 | 0.310 |
Why?
|
| Radiometry | 1 | 2010 | 64 | 0.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2015 | 304 | 0.310 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2011 | 631 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 7 | 2019 | 1304 | 0.280 |
Why?
|
| Humans | 44 | 2022 | 98362 | 0.270 |
Why?
|
| Lymph Nodes | 1 | 2011 | 563 | 0.260 |
Why?
|
| Microbubbles | 2 | 2025 | 44 | 0.260 |
Why?
|
| Prostatic Neoplasms | 5 | 2018 | 1842 | 0.240 |
Why?
|
| Burns | 3 | 2018 | 150 | 0.230 |
Why?
|
| Hydroxyl Radical | 1 | 2025 | 38 | 0.230 |
Why?
|
| Sensitivity and Specificity | 12 | 2015 | 1945 | 0.230 |
Why?
|
| Reproducibility of Results | 14 | 2015 | 2792 | 0.220 |
Why?
|
| Male | 21 | 2020 | 47257 | 0.220 |
Why?
|
| Bandages | 2 | 2018 | 43 | 0.210 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2014 | 325 | 0.210 |
Why?
|
| Neurosurgical Procedures | 4 | 2013 | 402 | 0.210 |
Why?
|
| Gadolinium | 2 | 2017 | 95 | 0.200 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 525 | 0.190 |
Why?
|
| Risk Factors | 3 | 2020 | 6271 | 0.180 |
Why?
|
| Gadolinium DTPA | 4 | 2013 | 239 | 0.170 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2021 | 34 | 0.170 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2021 | 53 | 0.170 |
Why?
|
| Silver Compounds | 2 | 2018 | 3 | 0.160 |
Why?
|
| Africa, Western | 1 | 2020 | 12 | 0.160 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 33 | 0.160 |
Why?
|
| Female | 18 | 2020 | 51756 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 180 | 0.150 |
Why?
|
| Healthy Volunteers | 2 | 2017 | 154 | 0.150 |
Why?
|
| Subtraction Technique | 2 | 2012 | 126 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2020 | 1009 | 0.150 |
Why?
|
| Musculoskeletal Diseases | 1 | 2019 | 38 | 0.150 |
Why?
|
| Craniotomy | 2 | 2011 | 100 | 0.150 |
Why?
|
| Middle Aged | 16 | 2020 | 29532 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 264 | 0.140 |
Why?
|
| Emulsions | 1 | 2018 | 20 | 0.140 |
Why?
|
| Aged | 12 | 2020 | 21844 | 0.140 |
Why?
|
| Liver | 2 | 2019 | 1230 | 0.140 |
Why?
|
| Animals | 10 | 2025 | 28981 | 0.130 |
Why?
|
| Arteries | 1 | 2018 | 172 | 0.120 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 128 | 0.120 |
Why?
|
| Laser Therapy | 1 | 2018 | 149 | 0.120 |
Why?
|
| Cadaver | 6 | 2012 | 203 | 0.120 |
Why?
|
| Temperature | 1 | 2017 | 442 | 0.120 |
Why?
|
| Ear, Inner | 3 | 2012 | 41 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1570 | 0.110 |
Why?
|
| Safety Management | 1 | 2015 | 54 | 0.110 |
Why?
|
| Prostheses and Implants | 2 | 2013 | 130 | 0.110 |
Why?
|
| Biomarkers | 1 | 2021 | 2021 | 0.110 |
Why?
|
| Ejaculation | 1 | 2014 | 9 | 0.100 |
Why?
|
| Equipment Failure Analysis | 2 | 2013 | 88 | 0.100 |
Why?
|
| Artificial Intelligence | 2 | 2010 | 478 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2017 | 11039 | 0.100 |
Why?
|
| Adult | 13 | 2017 | 29587 | 0.100 |
Why?
|
| Whole Body Imaging | 2 | 2010 | 40 | 0.090 |
Why?
|
| Body Temperature | 1 | 2013 | 128 | 0.090 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 220 | 0.090 |
Why?
|
| Equipment Design | 2 | 2013 | 425 | 0.090 |
Why?
|
| Multimodal Imaging | 1 | 2013 | 115 | 0.090 |
Why?
|
| Cranial Fossa, Middle | 1 | 2012 | 12 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2011 | 817 | 0.090 |
Why?
|
| Microvessels | 1 | 2012 | 70 | 0.090 |
Why?
|
| Facial Nerve | 1 | 2012 | 35 | 0.090 |
Why?
|
| Liver Neoplasms | 2 | 2008 | 826 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2011 | 24 | 0.090 |
Why?
|
| Prostate-Specific Antigen | 1 | 2013 | 356 | 0.080 |
Why?
|
| Synovial Fluid | 1 | 2011 | 13 | 0.080 |
Why?
|
| Breast Neoplasms | 3 | 2012 | 3285 | 0.080 |
Why?
|
| Amides | 1 | 2011 | 54 | 0.080 |
Why?
|
| Orbit | 1 | 2011 | 39 | 0.080 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 354 | 0.080 |
Why?
|
| Echo-Planar Imaging | 1 | 2011 | 49 | 0.080 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2011 | 78 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 281 | 0.080 |
Why?
|
| Carcinoma, Medullary | 1 | 2010 | 9 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 1 | 2012 | 356 | 0.080 |
Why?
|
| Electromagnetic Fields | 1 | 2010 | 26 | 0.080 |
Why?
|
| Curriculum | 1 | 2015 | 636 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2011 | 89 | 0.080 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2009 | 4 | 0.080 |
Why?
|
| Brain Mapping | 2 | 2011 | 570 | 0.080 |
Why?
|
| Petrous Bone | 1 | 2009 | 9 | 0.080 |
Why?
|
| Benzenesulfonates | 1 | 2010 | 49 | 0.080 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2009 | 24 | 0.080 |
Why?
|
| Knee Joint | 1 | 2011 | 179 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2012 | 268 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 1110 | 0.070 |
Why?
|
| Silver | 1 | 2009 | 15 | 0.070 |
Why?
|
| ROC Curve | 3 | 2019 | 793 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2014 | 2599 | 0.070 |
Why?
|
| Evoked Potentials | 1 | 2010 | 191 | 0.070 |
Why?
|
| Pregnancy | 1 | 2016 | 3269 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 75 | 0.070 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 80 | 0.070 |
Why?
|
| Temporal Bone | 1 | 2008 | 65 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 573 | 0.070 |
Why?
|
| Pyridines | 1 | 2010 | 316 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2548 | 0.070 |
Why?
|
| United States | 3 | 2021 | 8258 | 0.070 |
Why?
|
| Infant | 1 | 2014 | 3358 | 0.060 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 129 | 0.060 |
Why?
|
| Swine | 2 | 2019 | 593 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 621 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2014 | 4038 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2008 | 104 | 0.060 |
Why?
|
| Endoscopy | 1 | 2009 | 388 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 639 | 0.060 |
Why?
|
| Proteins | 1 | 2011 | 804 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2010 | 469 | 0.060 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2005 | 29 | 0.050 |
Why?
|
| Phospholipids | 1 | 2005 | 109 | 0.050 |
Why?
|
| Cognition | 1 | 2010 | 669 | 0.050 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 1195 | 0.050 |
Why?
|
| Adolescent | 2 | 2014 | 10137 | 0.050 |
Why?
|
| Child | 1 | 2014 | 7745 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 7418 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2013 | 331 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2014 | 340 | 0.040 |
Why?
|
| Reference Values | 1 | 2002 | 608 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 843 | 0.040 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 244 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2014 | 9770 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2014 | 4817 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2014 | 970 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2019 | 945 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2018 | 228 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2011 | 602 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 101 | 0.030 |
Why?
|
| Young Adult | 3 | 2012 | 7568 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 890 | 0.020 |
Why?
|
| Radio Waves | 1 | 2013 | 20 | 0.020 |
Why?
|
| Biomimetics | 1 | 2013 | 29 | 0.020 |
Why?
|
| Perfusion | 1 | 2014 | 271 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 1775 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 425 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 2012 | 74 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 194 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 302 | 0.020 |
Why?
|
| Ascites | 1 | 2011 | 55 | 0.020 |
Why?
|
| Models, Anatomic | 1 | 2011 | 88 | 0.020 |
Why?
|
| Computers | 1 | 2011 | 103 | 0.020 |
Why?
|
| Risk | 1 | 2012 | 660 | 0.020 |
Why?
|
| Elasticity | 1 | 2011 | 98 | 0.020 |
Why?
|
| Titanium | 1 | 2010 | 27 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2012 | 525 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 5576 | 0.020 |
Why?
|
| Lasers | 1 | 2010 | 105 | 0.020 |
Why?
|
| Meglumine | 1 | 2010 | 36 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2010 | 24 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2010 | 221 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2013 | 491 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2010 | 58 | 0.020 |
Why?
|
| Cerebellopontine Angle | 1 | 2009 | 10 | 0.020 |
Why?
|
| Microsurgery | 1 | 2011 | 121 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 105 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 579 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2009 | 20 | 0.020 |
Why?
|
| Semicircular Canals | 1 | 2009 | 30 | 0.020 |
Why?
|
| Deafness | 1 | 2009 | 50 | 0.020 |
Why?
|
| Cranial Sinuses | 1 | 2009 | 21 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 71 | 0.020 |
Why?
|
| Skin Temperature | 1 | 2009 | 16 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2010 | 112 | 0.020 |
Why?
|
| Contraindications | 1 | 2009 | 66 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 49 | 0.020 |
Why?
|
| Individuality | 1 | 2010 | 120 | 0.020 |
Why?
|
| Materials Testing | 1 | 2009 | 95 | 0.020 |
Why?
|
| Automation | 1 | 2009 | 118 | 0.020 |
Why?
|
| Organometallic Compounds | 1 | 2010 | 142 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 402 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 2008 | 33 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 676 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2008 | 64 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 195 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 907 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2009 | 418 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1539 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 467 | 0.020 |
Why?
|
| User-Computer Interface | 1 | 2008 | 194 | 0.020 |
Why?
|
| Software | 1 | 2011 | 697 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2011 | 2085 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 2005 | 14 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 509 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 183 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 1791 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 2050 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1785 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 4126 | 0.010 |
Why?
|
| Radiographic Image Enhancement | 1 | 2006 | 449 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2577 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4428 | 0.010 |
Why?
|